Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
01/1996
01/03/1996EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
01/03/1996EP0689549A1 New urea derivates, their preparation and their use
01/03/1996EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
01/03/1996EP0689428A1 Enhanced circulation effector composition and method
01/03/1996EP0580685B1 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration
01/02/1996US5481021 Phenyl amidines derivatives useful as platelet aggregation inhibitors
01/02/1996US5480998 Oxime derivative
01/02/1996CA1337891C Anf derivatives with novel bridging
12/1995
12/28/1995WO1995035313A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
12/28/1995WO1995035312A1 Arginine mimic derivatives as enzyme inhibitors
12/28/1995WO1995035311A1 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
12/28/1995WO1995035309A1 New thrombin inhibitors, their preparation and use
12/28/1995WO1995035276A1 Metalloproteinase inhibitors
12/28/1995WO1995035275A1 Metalloproteinase inhibitors
12/28/1995WO1995035117A1 Thrombolytic composition
12/28/1995WO1995035105A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide
12/28/1995WO1995032203A3 Use of tetrahydropteridine derivatives as no-synthase inhibitors
12/28/1995CA2193692A1 Metalloproteinase inhibitors
12/28/1995CA2193691A1 Metalloproteinase inhibitors
12/28/1995CA2193133A1 Novel thrombin inhibitors, the preparation and use thereof
12/28/1995CA2193100A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide
12/28/1995CA2192211A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
12/27/1995EP0688788A1 Boronic acid peptide derivatives having protease inhibiting activity, process for preparation thereof and pharmaceutical compositions comprising them
12/27/1995EP0688315A1 New heterocyclic compounds, their preparation and their use
12/27/1995EP0688221A1 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
12/27/1995EP0688211A1 Methods and compositions for inhibition of angiogenesis
12/27/1995EP0471811B1 Allosteric hemoglobin modifiers
12/27/1995CN1113915A Chemical compounds
12/26/1995US5478942 Cyclic urea derivatives and pharmaceutical compositions containing these compounds
12/26/1995US5478821 Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases
12/26/1995US5478810 Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors
12/26/1995US5478805 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
12/26/1995US5478558 Administering composition free of serum amyloid P, thrombin activity, infectious agents, antibodies
12/23/1995CA2152205A1 Boronic acid peptidic derivatives; process for preparing the same and pharmaceutical compositions containing them
12/21/1995WO1995034669A2 Retroviral gene therapy vectors and therapeutic methods based thereon
12/21/1995WO1995034572A1 THE PRODUCTION OF HEMOGLOBIN HAVING A δ-LIKE GLOBIN
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/21/1995WO1995034315A1 Radiolabeled annexin-galactose conjugates
12/21/1995WO1995034286A1 Transmucosal delivery system
12/21/1995CA2192066A1 The production of hemoglobin having a .delta.-like globin
12/21/1995CA2191845A1 Retroviral gene therapy vectors and therapeutic methods based thereon
12/20/1995EP0687687A2 Pharmaceutical compositions for prevention and treatment of blood coagulation disorders
12/20/1995EP0687256A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
12/20/1995EP0687254A1 4-aminopyridines, their preparation and their use as antithrombotic agent
12/20/1995EP0687253A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/20/1995CN1113493A Boron containing derivative and preparation and medical application of same
12/20/1995CN1113444A Chinese medicine liquid for curing scar and its preparation
12/19/1995US5476862 Activation of Protein C
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476846 Administering anti-thrombotic and anti-asthmatic agent
12/19/1995US5476777 Methods for producing thrombin
12/19/1995CA1337767C Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
12/14/1995WO1995033769A1 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
12/14/1995WO1995033763A1 Novel elastase inhibitors
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033483A1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases
12/14/1995WO1995032190A3 Pharmaceutical diketopiperazine compounds
12/13/1995EP0686642A2 Modified guanidino and amidino thrombin inhibitors
12/13/1995EP0686395A2 Use of hyaluronic acid for the manufacture of a medicament for the inhibition of platelet aggregation
12/13/1995EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
12/13/1995CN1113389A High molecular weight desulphatohirudin
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/08/1995CA2148977A1 Methods for the inhibition of platelet adherence and aggregation
12/07/1995WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation
12/07/1995WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
12/07/1995WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995DE4419315A1 New hetero- and oxo-pyrrolizine derivs.
12/07/1995DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
12/07/1995DE4419246A1 New hetero-aryl substd. pyrrolizine derivs.
12/07/1995DE19513784A1 Hochreines Urodilatin und Verfahren zu seiner Herstellung High purity urodilatin and process for its preparation
12/07/1995CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof
12/07/1995CA2191306A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation
12/06/1995EP0685492A2 Process for the preparation of hyperpolymers of haemoglobin with uniform molecular weight
12/06/1995EP0685490A1 Process for the purification of homogeneous platelet-derived endothelial cell growth factor from a platelet lysate
12/06/1995EP0685489A2 Tripeptide antithrombotic agents
12/06/1995EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
12/06/1995EP0684830A1 Inhibitors of thrombosis
12/06/1995EP0684828A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b)
12/06/1995EP0684823A1 Fibrinogen receptor antagonists
12/05/1995US5472979 1,2,3,4-tetrahydronaphthalene compounds
12/05/1995US5472959 Hypotensive agents, congestive heart failure
12/05/1995US5472942 Anti-thrombins
12/05/1995US5472939 Method of treating complement mediated disorders
12/05/1995US5472938 Pharmaceutical depot compositions containing hirudin
12/05/1995US5472692 Causes less fibrinogenolysis than native pro-urokinase; thrombolytic agents
12/05/1995CA1337688C Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
11/1995
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032203A2 Use of tetrahydropteridine derivatives as no-synthase inhibitors
11/30/1995WO1995032190A2 Pharmaceutical diketopiperazine compounds
11/30/1995DE4418635A1 Compsns. for treating excessive blood clotting
11/30/1995DE4418097A1 Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase Using Tetrahydropteridin derivatives as inhibitors of NO synthase
11/30/1995CA2190279A1 Pharmaceutical diketopiperazine compounds
11/30/1995CA2190247A1 Safe vectors for gene therapy
11/29/1995EP0684258A2 Tripeptide antithrombotic agents
11/29/1995EP0683789A1 N-alkyl-2-substituted atp analogues
1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 671